EU Proposal Gives Tissue Firms Only Two Years To Comply With New Regs
This article was originally published in The Gray Sheet
Executive Summary
Companies that market human tissue-engineered products (hTEP) in the European Union say they are alarmed by a new proposal from the European Commission that will give them only two years to comply with revised premarket regulations
You may also be interested in...
European Parliament Approves Revisions To Medical Device Directives
After adding new language on reprocessed devices, toxic substances and software, the European Parliament overwhelmingly approved a revision of the European Union's Medical Device Directives on March 29
European Parliament Approves Revisions To Medical Device Directives
After adding new language on reprocessed devices, toxic substances and software, the European Parliament overwhelmingly approved a revision of the European Union's Medical Device Directives on March 29
Regulation For Tissue-Engineered Products Moves Forward In Europe
Manufacturers of some tissue-engineered products on the European market would have four years to comply with a new regulation working its way through the European Union legislative process